74 followers
Link to our article about Study rationale and design of EMPA-CARD trial: investigating effect of SGLT2i (Empagliflozin) on inflammatory and oxidative status in patients with coronary artery disease funded by Dr. Abidi Pharmaceutical Company® https://t.co/q